Elucidation of Exosome Migration Across the Blood–Brain Barrier Model In Vitro

References 77

1. 1.

   Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci. 2006;7:41-53.

   Not in our library10.1038/nrn1824

2. 2.

   Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29:341-345.

   Not in our library10.1038/nbt.1807

3. 3.

   Andreone BJ, Lacoste B, Gu C. Neuronal and vascular interactions. Annu Rev Neurosci. 2015;38:25-46.

   Not in our library10.1146/annurev-neuro-071714-033835

4. 4.

   Banks WA. From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery. Nat Rev Drug Discov. 2016.

   Not in our library10.1038/nrd.2015.21

5. 5.

   Chen J, Zhang ZG, Li Y, Wang L, Xu YX, Gautam SC, Lu M, Zhu Z, Chopp M. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res. 2003;92:692-699.

   Not in our library10.1161/01.res.0000063425.51108.8d

6. 6.

   Colombo M, Raposo G, Thery C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255-289.

   Not in our library10.1146/annurev-cellbio-101512-122326

7. 7.

   Deli MA, Descamps L, Dehouck MP, Cecchelli R, Joo F, Abraham CS, Torpier G. Exposure of tumor necrosis factor-alpha to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin. J Neurosci Res. 1995;41:717-726.

   Not in our library10.1002/jnr.490410602

8. 8.

   Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol. 2015;15:545-558.

   Not in our library10.1038/nri3871

9. 9.

   Descamps L, Cecchelli R, Torpier G. Effects of tumor necrosis factor on receptor-mediated endocytosis and barrier functions of bovine brain capillary endothelial cell monolayers. J Neuroimmunol. 1997;74:173-184.

   Not in our library10.1016/s0165-5728(96)00226-3

10. 10.

    Dobson PD, Kell DB. Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule? Nat Rev Drug Discov. 2008;7:205-220.

    Not in our library10.1038/nrd2438

11. 11.

    Dulamea AO. The potential use of mesenchymal stem cells in stroke therapy-From bench to bedside. Journal of the Neurological Sciences. 2015;352:1-11.

    Not in our library10.1016/j.jns.2015.03.014

12. 12.

    El-Andaloussi S, Mager I, Breakefield XO, Wood MJ. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013;12:347-357.

    Not in our library10.1038/nrd3978

13. 13.

    Etame AB, Diaz RJ, Smith CA, Mainprize TG, Hynynen K, Rutka JT. Focused ultrasound disruption of the blood-brain barrier: a new frontier for therapeutic delivery in molecular neurooncology. Neurosurg Focus. 2012;32:E3.

    Not in our library10.3171/2011.10.focus11252

14. 14.

    Faille D, El-Assaad F, Mitchell AJ, Alessi MC, Chimini G, Fusai T, Grau GE, Combes V. Endocytosis and intracellular processing of platelet microparticles by brain endothelial cells. J Cell Mol Med. 2012;16:1731-1738.

    Not in our library10.1111/j.1582-4934.2011.01434.x

15. 15.

    Fischer S, Wiesnet M, Marti HH, Renz D, Schaper W. Simultaneous activation of several second messengers in hypoxia-induced hyperpermeability of brain derived endothelial cells. J Cell Physiol. 2004;198:359-369.

    Not in our library10.1002/jcp.10417

16. 16.

    Fruhbeis C, Frohlich D, Kramer-Albers EM. Emerging roles of exosomes in neuron-glia communication. Front Physiol. 2012;3:119.

    Not in our library10.3389/fphys.2012.00119

17. 17.

    Gabathuler R. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiol Dis. 2010;37:48-57.

    Not in our library10.1016/j.nbd.2009.07.028

18. 18.
    miRNA in Plasma Exosome is Stable under Different Storage Conditions · 2014

    No notice
19. 19.

    Hsu J, Rappaport J, Muro S. Specific binding, uptake, and transport of ICAM-1-targeted nanocarriers across endothelial and subendothelial cell components of the blood-brain barrier. Pharm Res. 2014;31:1855-1866.

    Not in our library10.1007/s11095-013-1289-8

20. 20.

    Imai T, Takahashi Y, Nishikawa M, Kato K, Morishita M, Yamashita T, Matsumoto A, Charoenviriyakul C, Takakura Y. Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice. J Extracell Vesicles. 2015;4:26238.

    Not in our library10.3402/jev.v4.26238

21. 21.

    Kalani A, Tyagi A, Tyagi N. Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics. Mol Neurobiol. 2014;49:590-600.

    Not in our library10.1007/s12035-013-8544-1

22. 22.

    Komarova Y, Malik AB. Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu Rev Physiol. 2010;72:463-493.

    Not in our library10.1146/annurev-physiol-021909-135833

23. 23.

    Kourembanas S. Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy. Annu. Rev. Physiol. 2015;77:13-27.

    Not in our library10.1146/annurev-physiol-021014-071641

24. 24.

    Lai CP, Mardini O, Ericsson M, Prabhakar S, Maguire CA, Chen JW, Tannous BA, Breakefield XO. Dynamic Biodistribution of Extracellular Vesicles in Vivo Using a Multimodal Imaging Reporter. Acs Nano. 2014;8:483-494.

    Not in our library10.1021/nn404945r

25. 25.

    Lasser C. Exosomes in diagnostic and therapeutic applications: biomarker, vaccine and RNA interference delivery vehicle. Expert Opin. Biol. Ther. 2015;15:103-117.

    Not in our library10.1517/14712598.2015.977250

26. 26.

    Lasser C, O’Neil SE, Ekerljung L, Ekstrom K, Sjostrand M, Lotvall J. RNA-containing exosomes in human nasal secretions. Am J Rhinol Allergy. 2011;25:89-93.

    Not in our library10.2500/ajra.2011.25.3573

27. 27.

    Lee CC, MacKay JA, Frechet JM, Szoka FC. Designing dendrimers for biological applications. Nat Biotechnol. 2005;23:1517-1526.

    Not in our library10.1038/nbt1171

28. 28.

    Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, Semprun-Prieto L, Delafontaine P, Prockop DJ. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 2009;5:54-63.

    Not in our library10.1016/j.stem.2009.05.003

29. 29.

    Liao W, Pham V, Liu L, Riazifar M, Pone EJ, Zhang SX, Ma F, Lu M, Walsh CM, Zhao W. Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis. Biomaterials. 2016;77:87-97.

    Not in our library10.1016/j.biomaterials.2015.11.005

30. 30.

    Liu L, Eckert MA, Riazifar H, Kang DK, Agalliu D, Zhao W. From blood to the brain: can systemically transplanted mesenchymal stem cells cross the blood-brain barrier? Stem Cells Int. 2013;2013:435093.

    Not in our library10.1155/2013/435093

31. 31.

    Liu L, Zhang SX, Aeran R, Liao W, Lu M, Polovin G, Pone EJ, Zhao W. Exogenous marker-engineered mesenchymal stem cells detect cancer and metastases in a simple blood assay. Stem Cell Res Ther. 2015;6:181.

    Not in our library10.1186/s13287-015-0151-9

32. 32.

    Manders EMM, Verbeek FJ, Aten JA. Measurement of Colocalization of Objects in Dual-Color Confocal Images. Journal of Microscopy-Oxford. 1993;169:375-382.

    Not in our library10.1111/j.1365-2818.1993.tb03313.x

33. 33.

    Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics. 2010;73:1907-1920.

    Not in our library10.1016/j.jprot.2010.06.006

34. 34.

    Mulcahy LA, Pink RC, Carter DR. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014;3.

    Not in our library10.3402/jev.v3.24641

35. 35.

    Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood-brain barrier. Nat Med. 2013;19:1584-1596.

    Not in our library10.1038/nm.3407

36. 36.

    Ohno S, Takanashi M, Sudo K, Ueda S, Ishikawa A, Matsuyama N, Fujita K, Mizutani T, Ohgi T, Ochiya T, Gotoh N, Kuroda M. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther. 2013;21:185-191.

    Not in our library10.1038/mt.2012.180

37. 37.

    Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, Moita CF, Schauer K, Hume AN, Freitas RP, Goud B, Benaroch P, Hacohen N, Fukuda M, Desnos C, Seabra MC, Darchen F, Amigorena S, Moita LF, Thery C. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010;12(supp 1– 13):19-30.

    Not in our library10.1038/ncb2000

38. 38.

    Pardridge WM. Targeted delivery of protein and gene medicines through the blood-brain barrier. Clin Pharmacol Ther. 2015;97:347-361.

    Not in our library10.1002/cpt.18

39. 39.

    Pardridge WM. Blood-brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery. Expert Opin Ther Targets. 2015;19:1059-1072.

    Not in our library10.1517/14728222.2015.1042364

40. 40.

    Pardridge WM. Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab. 2012;32:1959-1972.

    Not in our library10.1038/jcbfm.2012.126

41. 41.

    Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx. 2005;2:3-14.

    Not in our library10.1602/neurorx.2.1.3

42. 42.

    Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2:751-760.

    Not in our library10.1038/nnano.2007.387

43. 43.

    Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug. Discov. 2010;9:615-627.

    Not in our library10.1038/nrd2591

44. 44.

    Pols MS, Klumperman J. Trafficking and function of the tetraspanin CD63. Exp Cell Res. 2009;315:1584-1592.

    Not in our library10.1016/j.yexcr.2008.09.020

45. 45.

    Raposo G, Stoorvogel W. Extracellular vesicles: Exosomes, microvesicles, and friends. Journal of Cell Biology. 2013;200:373-383.

    Not in our library10.1083/jcb.201211138

46. 46.
    Extracellular Vesicle-Mediated Transfer of Genetic Information between the Hematopoietic System and the Brain in Response to Inflammation · 2014

    Corrected
47. 47.
    Downregulation of Blood-Brain Barrier Phenotype by Proinflammatory Cytokines Involves NADPH Oxidase-Dependent ROS Generation: Consequences for Interendothelial Adherens and Tight Junctions · 2014

    No notice
48. 48.

    Rubin LL, Staddon JM. The cell biology of the blood-brain barrier. Annu Rev Neurosci. 1999;22:11-28.

    Not in our library10.1146/annurev.neuro.22.1.11

49. 49.

    Sandoval KE, Witt KA. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis. 2008;32:200-219.

    Not in our library10.1016/j.nbd.2008.08.005

50. 50.

    Schiera G, Di Liegro CM, Di Liegro I. Extracellular membrane vesicles as vehicles for brain cell-to-cell interactions in physiological as well as pathological conditions. Biomed Research International. 2015.

    Not in our library10.1155/2015/152926

51. 51.

    Schnitzer JE, Oh P, Pinney E, Allard J. Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol. 1994;127:1217-1232.

    Not in our library10.1083/jcb.127.5.1217

52. 52.

    Shlosberg D, Benifla M, Kaufer D, Friedman A. Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nature Reviews Neurology. 2010;6:393-403.

    Not in our library10.1038/nrneurol.2010.74

53. 53.

    Song J. Ischemic apoplexy-induced sequelae treated by penetrating puncture with long needles. J Tradit Chin Med. 2002;22:200-202.

    Not in our library

54. 54.

    Sordi V, Malosio ML, Marchesi F, Mercalli A, Melzi R, Giordano T, Belmonte N, Ferrari G, Leone BE, Bertuzzi F, Zerbini G, Allavena P, Bonifacio E, Piemonti L. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood. 2005;106:419-427.

    Not in our library10.1182/blood-2004-09-3507

55. 55.
    Exosome Uptake Depends on ERK1/2-Heat Shock Protein 27 Signaling and Lipid Raft-mediated Endocytosis Negatively Regulated by Caveolin-1 · 2013

    No notice
56. 56.

    Takahashi Y, Nishikawa M, Shinotsuka H, Matsui Y, Ohara S, Imai T, Takakura Y. Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J Biotechnol. 2013;165:77-84.

    Not in our library10.1016/j.jbiotec.2013.03.013

57. 57.

    Takeshita Y, Obermeier B, Cotleur A, Sano Y, Kanda T, Ransohoff RM. An in vitro blood-brain barrier model combining shear stress and endothelial cell/astrocyte co-culture. J Neurosci Methods. 2014;232:165-172.

    Not in our library10.1016/j.jneumeth.2014.05.013

58. 58.

    Tannous BA, Kim DE, Fernandez JL, Weissleder R, Breakefield XO. Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther. 2005;11:435-443.

    Not in our library10.1016/j.ymthe.2004.10.016

59. 59.

    Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Chapter 3: Unit 3. Curr Protoc Cell Biol. 2006;22.

    Not in our library10.1002/0471143030.cb0322s30

60. 60.

    Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9:581-593.

    Not in our library10.1038/nri2567

61. 61.

    Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2:569-579.

    Not in our library10.1038/nri855

62. 62.

    Thompson AG, Gray E, Heman-Ackah SM, Mager I, Talbot K, Andaloussi SE, Wood MJ, Turner MR. Extracellular vesicles in neurodegenerative disease - pathogenesis to biomarkers. Nat Rev Neurol. 2016;12:346-357.

    Not in our library10.1038/nrneurol.2016.68

63. 63.

    Tian T, Zhu YL, Zhou YY, Liang GF, Wang YY, Hu FH, Xiao ZD. Exosome uptake through clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 delivery. J Biol Chem. 2014;289:22258-22267.

    Not in our library10.1074/jbc.m114.588046

64. 64.

    Torchilin VP. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat. Rev. Drug Discov. 2014;13:813-827.

    Not in our library10.1038/nrd4333

65. 65.

    Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4:145-160.

    Not in our library10.1038/nrd1632

66. 66.

    Trumpp A, Essers M, Wilson A. Awakening dormant haematopoietic stem cells. Nat Rev Immunol. 2010;10:201-209.

    Not in our library10.1038/nri2726

67. 67.
    Drug Delivery Systems, CNS Protection, and the Blood Brain Barrier · 2014

    No notice
68. 68.

    Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654-659.

    Not in our library10.1038/ncb1596

69. 69.

    Vercauteren D, Vandenbroucke RE, Jones AT, Rejman J, Demeester J, De Smedt SC, Sanders NN, Braeckmans K. The use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfalls. Mol Ther. 2010;18:561-569.

    Not in our library10.1038/mt.2009.281

70. 70.

    Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003;10:45-65.

    Not in our library10.1038/sj.cdd.4401189

71. 71.

    Whalen GF, Shing Y, Folkman J. The fate of intravenously administered bFGF and the effect of heparin. Growth Factors. 1989;1:157-164.

    Not in our library10.3109/08977198909029125

72. 72.

    Wolburg H, Lippoldt A. Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul Pharmacol. 2002;38:323-337.

    Not in our library10.1016/s1537-1891(02)00200-8

73. 73.
    Exosomes/miRNAs as mediating cell-based therapy of stroke · 2014

    No notice
74. 74.

    Xin H, Li Y, Cui Y, Yang JJ, Zhang ZG, Chopp M. Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab. 2013;33:1711-1715.

    Not in our library10.1038/jcbfm.2013.152

75. 75.

    Yang T, Martin P, Fogarty B, Brown A, Schurman K, Phipps R, Yin VP, Lockman P, Bai S. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio. Pharm Res. 2015;32:2003-2014.

    Not in our library10.1007/s11095-014-1593-y

76. 76.

    Zhang Y, Chopp M, Meng Y, Katakowski M, Xin H, Mahmood A, Xiong Y. Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury. J Neurosurg. 2015;122:856-867.

    Not in our library10.3171/2014.11.jns14770

77. 77.

    Zhuang X, Xiang X, Grizzle W, Sun D, Zhang S, Axtell RC, Ju S, Mu J, Zhang L, Steinman L, Miller D, Zhang HG. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther. 2011;19:1769-1779.

    Not in our library10.1038/mt.2011.164

Cited by papers we hold 29

• Cell–cell communication: new insights and clinical implications · 2024
  No notice
• Insights into Exosome Transport through the Blood–Brain Barrier and the Potential Therapeutical Applications in Brain Diseases · 2023
  No notice
• From Tumor Cells to Endothelium and Gut Microbiome: A Complex Interaction Favoring the Metastasis Cascade · 2022
  Not checked
• Insight into Extracellular Vesicle-Cell Communication: From Cell Recognition to Intracellular Fate · 2022
  No notice
• Exosomes derived from bone-marrow mesenchymal stem cells alleviate cognitive decline in AD-like mice by improving BDNF-related neuropathology · 2022
  No notice
• Neuron secrete exosomes containing miR-9-5p to promote polarization of M1 microglia in depression · 2022
  No notice
• Extracellular vesicles through the blood–brain barrier: a review · 2022
  No notice
• Biological Features of Extracellular Vesicles and Challenges · 2022
  No notice
• Exosome Processing and Characterization Approaches for Research and Technology Development · 2022
  No notice
• Exosomes: Potential Disease Biomarkers and New Therapeutic Targets · 2021
  No notice
• Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies · 2021
  No notice
• Mesenchymal Stem Cell-Derived Exosomes Ameliorate Alzheimer’s Disease Pathology and Improve Cognitive Deficits · 2021
  No notice
• Exosome-Derived MicroRNAs of Human Milk and Their Effects on Infant Health and Development · 2021
  No notice
• The Evolving Landscape of Exosomes in Neurodegenerative Diseases: Exosomes Characteristics and a Promising Role in Early Diagnosis · 2021
  No notice
• Exosomal delivery of therapeutic modulators through the blood–brain barrier; promise and pitfalls · 2021
  No notice
• Astrocyte Activation in Neurovascular Damage and Repair Following Ischaemic Stroke · 2021
  No notice
• Biodistribution of Exosomes and Engineering Strategies for Targeted Delivery of Therapeutic Exosomes · 2021
  No notice
• Unlocking the Power of Exosomes for Crossing Biological Barriers in Drug Delivery · 2021
  No notice
• Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation · 2020
  No notice
• Current Knowledge and Future Perspectives on Mesenchymal Stem Cell-Derived Exosomes as a New Therapeutic Agent · 2020
  No notice

and 9 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.